Ritva Koskela

Oulu, Finland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Ustekinumab for ulcerative colitis: a nationwide real-life observational cohort study.

Ustekinumab for ulcerative colitis: a nationwide real-life observational cohort study.

Journal: European journal of gastroenterology & hepatology

Published: February 19, 2025

Pregnancy period and early-life risk factors for inflammatory bowel disease: a Northern Finland birth cohort 1966 study.

Pregnancy period and early-life risk factors for inflammatory bowel disease: a Northern Finland birth cohort 1966 study.

Journal: BMC public health

Published: December 20, 2023

Real-life treatment persistence and treatment outcomes of Finnish patients with inflammatory bowel disease receiving vedolizumab as first-line biological treatment.

Real-life treatment persistence and treatment outcomes of Finnish patients with inflammatory bowel disease receiving vedolizumab as first-line biological treatment.

Journal: Heliyon

Published: October 17, 2023

Short interruptions of TNF-inhibitor treatment can be associated with treatment failure in patients with immune-mediated diseases.

Short interruptions of TNF-inhibitor treatment can be associated with treatment failure in patients with immune-mediated diseases.

Journal: Autoimmunity

Published: April 28, 2022

Serological Biomarker Panel in Diagnosis of Atrophic Gastritis and Helicobacter pylori Infection in Gastroscopy Referral Patients: Clinical Validation of the New-Generation GastroPanel® Test.

Serological Biomarker Panel in Diagnosis of Atrophic Gastritis and Helicobacter pylori Infection in Gastroscopy Referral Patients: Clinical Validation of the New-Generation GastroPanel® Test.

Journal: Anticancer research

Published: September 04, 2021

A nationwide real-world study on dynamic ustekinumab dosing and concomitant medication use among Crohn's disease patients in Finland.

A nationwide real-world study on dynamic ustekinumab dosing and concomitant medication use among Crohn's disease patients in Finland.

Journal: Scandinavian journal of gastroenterology

Published: April 06, 2021

Inflammatory Bowel Disease in Patients with Congenital Chloride Diarrhoea.

Inflammatory Bowel Disease in Patients with Congenital Chloride Diarrhoea.

Journal: Journal of Crohn's & colitis

Published: March 26, 2021

Objectively assessed disease activity and drug persistence during ustekinumab treatment in a nationwide real-world Crohn's disease cohort.

Objectively assessed disease activity and drug persistence during ustekinumab treatment in a nationwide real-world Crohn's disease cohort.

Journal: European journal of gastroenterology & hepatology

Published: September 02, 2020

A jaundiced patient at the emergency department.

A jaundiced patient at the emergency department.

Journal: Duodecim; laaketieteellinen aikakauskirja

Published: January 01, 2016

Does fecal calprotectin predict short-term relapse after stopping TNFα-blocking agents in inflammatory bowel disease patients in deep remission?

Does fecal calprotectin predict short-term relapse after stopping TNFα-blocking agents in inflammatory bowel disease patients in deep remission?

Journal: Journal of Crohn's & colitis

Published: July 24, 2014

Outcome after discontinuation of TNFα-blocking therapy in patients with inflammatory bowel disease in deep remission.

Outcome after discontinuation of TNFα-blocking therapy in patients with inflammatory bowel disease in deep remission.

Journal: Inflammatory bowel diseases

Published: May 07, 2014

A domestic human case of hepatitis E in Finland

A domestic human case of hepatitis E in Finland

Journal: Duodecim; laaketieteellinen aikakauskirja

Published: December 18, 2013

Showing 1-12 of 13

Last Updated: 09/26/2026